相关实验视频
Updated: Jan 9, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.9K
患有心肌病的患者的膝盖关节整形术:一个大匹配队列分析
Hayden Flume1, Clarissa Meza2, Megan Sorich2
1Texas College of Osteopathic Medicine, UNT Health Fort Worth, 3500 Camp Bowie Blvd, Fort Worth, TX, 76107, USA.
Journal of orthopaedics
|December 11, 2025
概括
接受全膝关节整形术 (TKA) 的心肌病患者面临各种术后并发症的风险显著增加. 这些包括心脏问题,血栓,感染和再入院,突出显示心肌病是关键的危险因素.
科学领域:
- 整形外科手术 整形外科手术
- 心脏病学 心脏病学
- 健康 结果 研究 研究 结果
背景情况:
- 心肌病包括各种心肌疾病,可能需要骨科手术,如全膝关节整形术 (TKA).
- 了解TKA与心肌病患者相关的风险对于术后管理和患者咨询至关重要.
研究的目的:
- 调查TKA接受心肌病患者的人口特征和30天术后并发症.
- 为了比较患有心肌病症和没有心肌病症的患者之间的TKA结果.
主要方法:
- 一项使用PearlDiver数据库的回顾性队列研究.
- 包括接受TKA的心肌病患者,通过ICD-9,ICD-10和CPT代码确定.
- 1:1的倾向分数匹配以比较群体之间的结果,统计显著性设置为p < 0.05.
主要成果:
- 患有心肌病的患者年龄较大,患上充血性心力衰竭 (3.076x),急性心肌梗塞 (2.45x),术后休克 (1.99x),深静脉血栓 (1.25x),肺栓塞 (1.56x),败血症 (1.37x) 和急性损伤 (1.36x) 的风险显著增加.
- 对于再录取 (1.23x) 和修订 (1.26x) 也观察到增加的风险.
- 在心肌病组中,局部并发症包括周围假肢关节感染,机械并发症,在麻醉下操纵和伤口脱光更频繁.
结论:
- 心肌病显著与TKA后主要不良心血管事件,血栓栓塞事件,传染性并发症和急性器官功能障碍的风险增加有关.
- 这些发现强调心肌病是膝关节整形术后不良术后结果的关键风险因素.
- 这些结果强调需要对接受TKA的心肌病患者进行精心的术前风险评估和量身定制的术后护理.
相关概念视频
Cardiomyopathy V: Interprofessional Care
313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Cardiomyopathy IV: Restrictive Cardiomyopathy
426
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
426
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Cardiomyopathy VII: Pre and Post Operative Nursing Management
257
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
257

